Inteliview
Log inSign up
IPO Tracker
N

뉴럴링크

Neuralink

USRumored
Valuation$10B
Expected--
SectorHealthcare
Exchange--
OVERVIEW

Neuralink is Elon Musk's brain-computer interface (BCI) company. It began human trials in 2024 and has demonstrated successful thought-controlled device operation by paralyzed patients. No IPO is planned.

HIGHLIGHTS
["First human trial (N1 implant) succeeded in 2024","Paralyzed patients controlling cursors and games by thought","Valued at ~$10B, founded by Elon Musk","FDA Breakthrough Device Designation received"]
RELATED IPOS
Picard Medical, Inc.
Picard Medical, Inc.Picard Medical, Inc.US · --
HealthLynked Corp
HealthLynked CorpHealthLynked CorpUS · --
Onconetix, Inc.
Onconetix, Inc.Onconetix, Inc.US · --
A
Aperture ACAperture ACUS · --
Next Bridge Hydrocarbons, Inc.
Next Bridge Hydrocarbons, Inc.Next Bridge Hydrocarbons, Inc.US · --
VEEA INC.
VEEA INC.VEEA INC.US · --
FAQ

When is the Neuralink IPO expected?

The Neuralink IPO is currently in the Rumored stage. Timelines may change based on market conditions.

What is Neuralink's valuation?

Neuralink's estimated valuation is approximately $10B. It operates in the Healthcare sector. The final valuation will depend on IPO pricing and market demand.

Can retail investors participate in the Neuralink IPO?

U.S. IPOs are typically allocated to institutional investors first. Retail investors can purchase shares on NYSE/NASDAQ after listing. Some brokerages offer IPO access programs for pre-IPO allocation.

What does Neuralink do?

Neuralink is Elon Musk's brain-computer interface (BCI) company. It began human trials in 2024 and has demonstrated successful thought-controlled device operation by paralyzed patients. No IPO is planned.